The effect of postnatal steroids on growth and development

被引:32
作者
Halliday, HL
机构
[1] Royal Matern Hosp, Reg Neonatal Unit, Belfast BT12 6BB, Antrim, North Ireland
[2] Queens Univ Belfast, Dept Child Hlth, Belfast BT7 1NN, Antrim, North Ireland
关键词
adverse effects; chronic lung disease; corticosteroids; dexamethasone; growth and development; preterm infants;
D O I
10.1515/JPM.2001.040
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Single courses of prenatal corticosteroids have many beneficial effects including reduction in respiratory distress syndrome, intraventricular hemorrhage and neonatal mortality. Postnatal corticosteroids, however, have both beneficial and harmful effects, The beneficial effects include shortened time on the ventilator and a reduction in chronic lung disease. Dexamethasone treatment started within the first 4 days of life is associated with an increased risk of abnormal neurodevelopment including cerebral palsy. Other adverse effects include metabolic disturbances, cardiac hypertrophy, reduced growth and gastrointestinal perforation. The risks of early dexamethasone treatment in currently used doses outweigh the benefits. Further research is needed to determine the optimal corticosteroid drug, its dose and timing of administration to maximize benefit and reduce risk to a minimum. Other non-drug interventions should be used to minimize the risk of chronic lung disease in very preterm infants.
引用
收藏
页码:281 / 285
页数:5
相关论文
共 48 条
  • [1] Altman H, 1965, S Afr Med J, V39, P746
  • [2] Methylprednisolone, an alternative to dexamethasone in very premature infants at risk of chronic lung disease
    André, B
    Thébaud, B
    Odièvre, MH
    Razafimahefa, H
    Zupan, V
    Dehan, M
    Lacaze-Masmonteil, T
    [J]. INTENSIVE CARE MEDICINE, 2000, 26 (10) : 1496 - 1500
  • [3] AVERY GB, 1985, PEDIATRICS, V75, P106
  • [4] BADEN M, 1972, PEDIATRICS, V50, P526
  • [5] Anti-inflammatory actions of glucocorticoids: molecular mechanisms
    Barnes, PJ
    [J]. CLINICAL SCIENCE, 1998, 94 (06) : 557 - 572
  • [6] Baud O, 1999, ARCH DIS CHILD-FETAL, V80, pF159
  • [7] Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants
    Baud, O
    Foix-L'Helias, L
    Kaminski, M
    Audibert, F
    Jarreau, PH
    Papiernik, E
    Huon, C
    Lepercq, J
    Dehan, M
    Lacaze-Masmonteil, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (16) : 1190 - 1196
  • [8] Bensky AS, 1996, PEDIATRICS, V97, P818
  • [9] CATABOLIC EFFECT OF DEXAMETHASONE IN THE PRETERM BABY
    BROWNLEE, KG
    NG, PC
    HENDERSON, MJ
    SMITH, M
    GREEN, JH
    DEAR, PRF
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1992, 67 (01): : 1 - 4
  • [10] Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: A novel glucocorticoid hierarchy
    Buttgereit, F
    Brand, MD
    Burmester, GR
    [J]. BIOCHEMICAL PHARMACOLOGY, 1999, 58 (02) : 363 - 368